Petredis Investment Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.46M Buy
37,247
+44
+0.1% +$10.3K 0.64% 36
2026
Q1
$9.09M Sell
37,203
-347
-0.9% -$80.8K 0.74% 33
2025
Q4
$7.77M Sell
37,550
-401
-1% -$79.3K 0.61% 36
2025
Q3
$7.04M Sell
37,951
-223
-0.6% -$38.2K 0.56% 38
2025
Q2
$5.83M Buy
38,174
+522
+1% +$80.2K 0.51% 43
2025
Q1
$6.24M Buy
37,652
+924
+3% +$145K 0.65% 33
2024
Q4
$5.31M Sell
36,728
-1,306
-3% -$202K 0.55% 41
2024
Q3
$6.16M Buy
38,034
+118
+0.3% +$18.8K 0.66% 33
2024
Q2
$5.54M Buy
37,916
+8
+0% +$1.19K 0.62% 36
2024
Q1
$6M Buy
37,908
+932
+3% +$148K 0.72% 34
2023
Q4
$5.8M Sell
36,976
-992
-3% -$152K 0.76% 33
2023
Q3
$5.91M Buy
37,968
+104
+0.3% +$17.2K 0.84% 31
2023
Q2
$6.27M Sell
37,864
-39
-0.1% -$6.29K 0.86% 28
2023
Q1
$5.87M Buy
37,903
+674
+2% +$109K 0.92% 28
2022
Q4
$6.58M Buy
+37,229
New +$6.43M 1.19% 21

Other funds holding JNJ

Petredis Investment Advisors's JNJ Position: Q2 2026 in Review

Petredis Investment Advisors increased its Johnson & Johnson (JNJ) stake by 0.12% in Q2 2026, buying an estimated $10.3K and bringing the position to 37,247 shares worth $9.46M. The position accounts for 0.64% of the portfolio, ranked #36.

Petredis Investment Advisors first reported a position in JNJ in Q4 2022 and has held it in 15 quarters since. 1,021 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Petredis Investment Advisors held 37,247 shares of Johnson & Johnson worth $9.46M as of Q2 2026.
  • Petredis Investment Advisors bought 44 Johnson & Johnson shares in Q2 2026, an estimated $10.3K.
  • Johnson & Johnson made up 0.64% of Petredis Investment Advisors's portfolio in Q2 2026, its #36 holding.
  • Petredis Investment Advisors first reported a position in Johnson & Johnson in Q4 2022 and has held it in 15 quarters since.
  • 1,021 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Petredis Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.